Ertapenem Resistance of Escherichia coli
نویسندگان
چکیده
An ertapenem-resistant Escherichia coli isolate was recovered from peritoneal fluid in a patient who had been treated with imipenem/cilastatin for 10 days. Ertapenem resistance may be explained by a defect in the outer membrane protein and production of extended-spectrum beta-lactamase CTX-M-2.
منابع مشابه
Comparison of ertapenem non-susceptibility with 2-mercaptopropionic acid phenotypic tests in predicting NDM-1 and IMP-1 production in clinical isolates of Escherichia coli
Background: A routine phenotypic test has not been recommended for detection of metallo-β-lactamases (MBLs) producing Enterobacteriaceae species such as Escherichia coli. The current study was conducted to compare the 2-Mercaptopropionic acid (2-MPA) phenotypic method and ertapenem non-susceptibility test with polymerase chain reaction in predicting the production of MBLs in clinical isolates o...
متن کاملEmergence of ertapenem resistance in an Escherichia coli clinical isolate producing extended-spectrum beta-lactamase AmpC.
Escherichia coli isolate MEV, responsible for a bloodstream infection, was resistant to penicillins, cephalosporins, and ertapenem. Molecular and biochemical characterization revealed the production of a novel, chromosome-borne, extended-spectrum AmpC (ESAC) β-lactamase with a Ser-282 duplication and increased carbapenemase activity. This study demonstrates for the first time that chromosome-bo...
متن کاملPharmacodynamic activity of ertapenem versus genotypically characterized extended-spectrum b-lactamase (ESBL)-, KPC- or NDM-producing Escherichia coli with reduced susceptibility or resistance to ertapenem using an in vitro model
Methods: Fifteen extended-spectrum b-lactamaseor carbapenemase-producing E. coli were studied. The in vitro pharmacodynamic model was inoculated with 1×10 cfu/mL and ertapenem was dosed once daily at 0 and 24 h to simulate free ( f ) Cmax and t12 obtained after either 1 g or 2 g intravenous once-daily doses in healthy volunteers (1 g: f Cmax 15 mg/L, t12 4 h). Sampling was performed over 48 h t...
متن کاملClinical Efficacy of Ertapenem for Recurrent Cystitis Caused by Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli in Female Outpatients
PURPOSE To evaluate the clinical outcomes of ertapenem administered as an outpatient parenteral antibiotic therapy for intractable cystitis caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. MATERIALS AND METHODS We retrospectively reviewed a case series of 3 years of therapeutic experience with ertapenem for intractable recurrent cystitis caused by ESBL-producing E. c...
متن کاملThe Determination of Carbapenem Resistance in Escherichia Coli and Klebsiella Pneumoniae Isolates Related to Nosocomial Infections and the Evaluation of Risk Factors
We aimed to investigate carbapenem resistance, resistance mechanisms, risk factors and epidemiological features of Escherichia coli and Klebsiella pneumoniae strains isolated from related infections in intensive care unit (ICU) patients. Carbapenemase activity was determined by MHT, MBL Etest and enzyme extraction methods. Presence of extended-spectrum b-lactamase (ESBL) and carbapenemaseencodi...
متن کامل